跳至主要内容
临床试验/EUCTR2017-002101-35-DK
EUCTR2017-002101-35-DK进行中(未招募)1 期

THE ROLE OF HYPERGLYCEMIA, HYPERINSULINEMIA AND ELEVATED FREE FATTY ACIDS FOR CARDIAC FUNCTION IN PATIENTS WITH TYPE 2 DIABETES – THE HYPERCARD2 STUDY - HyperCarD2

Sten Madsbad0 个研究点目标入组 20 人开始时间: 2017年6月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Elegible for inclusion are male patients aged =18 years with T2DM who are either drug naïve (no anti-diabetes agents for =12 weeks prior to randomization) with HbA1c =10.0% or taking any background anti-diabetes therapy (except insulin) with HbA1c =9.0% despite diet and exercise counseling.
  • 6.1 INCLUSION CRITERIA:
  • Age = 18 years
  • BMI = 28 kg/m2
  • HbA1c = 9.0% (=10% in diet or metformin only treated patients)
  • Fasting C-peptide = 500 pmol/L
  • Unchanged antiglycemic treatment 12 weeks prior to inclusion as assessed by investigator
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 12
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • EXCLUSION CRITERIA:
  • Insulin treatment within 3 months of informed consent
  • Type 1 diabetes
  • Psychiatric disorder or mental retardation
  • Drug or alcohol abuse within 3 months from informed consent
  • Poor compliance
  • Anemia (hgb = 6.4 mmol/L) or other blood dyscrasias causing hemolysis or unstable red blood cells
  • Indication of liver disease, defined by serum levels of alanine amininotransferase, aspartate aminotransferase, or alkaline phosphatase above 3 x upper limit
  • Impaired renal function (eGFR<45ml/min/1.73 m2)
  • Treatment with anti-obesity drugs 3 months prior to informed consent
  • Systemic steroid treatment within 6 weeks of informed consent
  • Uncontrolled thyroid disease (prescribed changes in thyroid medication within the 6 weeks prior to informed consent)
  • Any uncontrolled endocrine disorder except type 2 diabetes
  • Bariatric surgery or other gastrointestinal disorders that compromises gastrointestinal absorption
  • Peptic ulcer – verified by endoscopically
  • Any form of planned surgery within 3 months of informed consent
  • Acute coronary syndrome, stroke or TCI within 2 months prior to informed consent
  • Persistent atrial fibrillation
  • Inability to undergo experimental procedures including exclusion criteria for MRI scanning:
  • oImplantable cardioverter defibrillator/pacemaker
  • oFerromagnetic clips
  • oClaustrophobia.
  • Contraindication to glycopyrrolate infusion:
  • oKnown closed-angle glaucoma
  • oknown severe prostate hyperplasia
  • oTachycardia (HR > 100 at rest)
  • oKnown bladder atony
  • oCardia insufficiency or non-congenital pylorus stenosis – verified endoscopically
  • oKnown gastroparesis
  • Allergy towards any of the drugs or diagnostics used in the protocol (insulin, empagliflozin, acipimox, glycopyrrolate, adenosine, gadolinium contrast enhancer).
  • Any condition which in the opinion of the investigator may jeopardize subject safety or compliance with the protocol

研究者

发起方
Sten Madsbad

相似试验

已完成
不适用
The changes in blood glucose during weights exercise in individuals with type 1 diabetes, with a view to improve exercise-associated fluctuations in blood glucoseNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusType 1 diabetes
ISRCTN60407046Swansea University (UK)12
进行中(未招募)
不适用
Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery - Role of insulin glucose potassium magnesium in cardiac surgeryWe propose to recruit 90 patients (based on the power calculation) undergoing first time urgent in-house CABG at Morriston Hospital. The decision to operate on an urgent basis will be based on the severity of coronary disease and symptoms. After informed consent, patients will be randomly assigned to eithe rcontrol, HDIGK (High dose Insulin, Glucose, Potassium) or HDIGKM (High dose Insulin, Glucose, Potassium, Magnesium) group according to a random allocation table
EUCTR2004-002850-69-GBSwansea NHS Trust90
已完成
不适用
Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shockMeningococcal sepsisInfections and InfestationsMeningococcal infection
ISRCTN68283215Erasmus Medical Centre, Sophia Children?s Hospital (Netherlands)80
招募中
不适用
Prevalence of hypoglycaemia during extended oral glucose tolerance test in people with Cystic FibrosisCystic Fibrosis
ACTRN12616001175460Academic Department of Adolescent Medicine25
已完成
不适用
An observational study to assess degree of diabetes control in terms of glycated haemoglobin, proportion of patients having diabetic complications and future risk of heart disease in diabetic patients receiving antidiabetic medication.
CTRI/2018/03/012806Shraddha M Pore221